Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Current issue

Page Path
HOME > Browse articles > Current issue
27 Current issue
Filter
Filter
Article category
Keywords
Authors
Funded articles
Volume 59(5); September 2026
Prev issue Next issue
Reviews
Advanced endoscopy and artificial intelligence-enabled vascular healing for ulcerative colitis: promising frontiers or mere mirage?
Yasuharu Maeda, Shin-ei Kudo, Takanori Kuroki, Yurie Kawabata, Jun Ohara, Katsuro Ichimasa, Noriyuki Ogata, Kazuo Ohtsuka, Masashi Misawa
Clin Endosc 2026;59(5):689-702.   Published online December 15, 2025
DOI: https://doi.org/10.5946/ce.2025.186
AbstractAbstract PDF
Ulcerative colitis, a chronic inflammatory bowel disease, is characterized by subtle microvascular alterations that play a critical role in disease perpetuation and mucosal injury. Recent advances in image-enhanced endoscopy and ultrahigh-magnification endoscopy have improved the real-time visualization of these vascular changes while highlighting their diagnostic value. Artificial intelligence (AI)-enabled endoscopic systems provide automated, reproducible vascular assessments. Emerging data suggest that AI-based vascular healing correlates with clinical remission and may alter histological scores, enabling the prediction of sustained remission. Despite these promising advances, challenges remain, such as standardizing vascular healing definitions, addressing interobserver variability, and validating AI-driven platforms in real-world settings. Integrating microvascular-targeted therapies and advanced imaging has the potential to transform the management of ulcerative colitis, facilitating sustained remission and improving the quality of life. This review examined the evolving role of microvascular assessment in ulcerative colitis, the potential of AI in refining endoscopic evaluation, and the prospects of incorporating vascular healing as a therapeutic target.

Citations

Citations to this article as recorded by  
  • A Scoping Review of Endoscopic Assessment Considering Disease Extent in Ulcerative Colitis: Insights for the Artificial Intelligence Era
    Yasuharu Maeda, Shin-ei Kudo, Takanori Kuroki, Yurie Kawabata, Katsuro Ichimasa, Masashi Misawa, Noriyuki Ogata, Kazuo Ohtsuka
    Gut and Liver.2026; 20(4): 511.     CrossRef
  • 5,016 View
  • 384 Download
  • 2 Web of Science
  • 1 Crossref
Close layer
Palliative endoscopic biliary drainage for malignant hilar biliary obstruction
Shuji Mitsuhashi, Manik Aggarwal, Vinay Chandrasekhara
Clin Endosc 2026;59(5):703-715.   Published online March 31, 2026
DOI: https://doi.org/10.5946/ce.2025.395
AbstractAbstract PDF
Malignant hilar biliary obstruction (MHBO) is most commonly caused by cholangiocarcinoma or gallbladder cancer and frequently presents with obstructive jaundice, pruritus, and/or cholangitis. These symptoms impair performance status and delay the initiation of chemotherapy, making biliary drainage essential for both palliation and oncologic treatment. Endoscopic transpapillary biliary stenting via endoscopic retrograde cholangiopancreatography is the standard approach for biliary decompression. In patients with unresectable disease, either plastic or self-expandable metal stents may be used. Optimal outcomes are achieved when drainage encompasses more than 50% of functional liver volume, while atrophic segments should be avoided. When transpapillary access is not feasible or unsuccessful, alternative approaches such as percutaneous transhepatic biliary drainage or endoscopic ultrasound-guided biliary drainage may be considered. Adjunctive therapies, including photodynamic therapy and radiofrequency ablation, are being investigated to enhance local tumor control and prolong stent patency. With continued advances in stent technology, imaging modalities, and endoscopic techniques, the management of MHBO is expected to become increasingly individualized and effective.
  • 5,421 View
  • 400 Download
Close layer
Endobiliary radiofrequency ablation for malignant biliary obstruction: clinical benefits, limitations, and future directions
Tadahisa Inoue, Huapyong Kang, Jae Hee Cho
Clin Endosc 2026;59(5):716-725.   Published online July 1, 2026
DOI: https://doi.org/10.5946/ce.2025.475
AbstractAbstract PDF
Endobiliary radiofrequency ablation (EB-RFA) is an adjunctive local therapy performed during endoscopic biliary drainage for malignant biliary obstruction. EB-RFA was originally introduced to reduce the intraductal tumor burden and maintain biliary drainage, and has been investigated for its potential survival benefits, especially for patients with extrahepatic cholangiocarcinoma (eCCA). However, the available evidence shows heterogeneity, and recent large trials have reported neutral results. This review summarizes the current evidence regarding the clinical benefits and limitations of EB-RFA, focusing on its effects on survival and stent patency. Existing data suggest that the survival benefit associated with EB-RFA is greater in patients with eCCA without distant metastasis than in those with metastatic disease. Evidence of its efficacy in improving stent patency is inconsistent based on the findings of randomized trials. However, observational studies, particularly those involving uncovered self-expandable metal stents, have reported its benefits. EB-RFA may also be considered for reintervention in cases involving metal stents occluded due to tumor ingrowth; however, clinical success may be suboptimal due to imperfect tissue contact and technical factors. Future studies with standardized protocols and predefined subgroup analyses are required to define optimal candidates and clinically meaningful endpoints, especially in the context of evolving systemic therapy.
  • 2,584 View
  • 223 Download
Close layer
Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound-guided primary biliary drainage for malignant distal biliary obstruction: a review
Shawn Chun Sum Teoh, Anthony Yuen Bun Teoh
Clin Endosc 2026;59(5):726-731.   Published online September 14, 2026
DOI: https://doi.org/10.5946/ce.2026.122
AbstractAbstract PDF
Approximately 70% of pancreatic cancers arising in the head of the pancreas cause malignant distal biliary obstruction. Therefore, biliary drainage is an important aspect of the management of these patients. Conventionally, the technique for relieving biliary obstruction has been endoscopic retrograde cholangiopancreatography (ERCP). When ERCP cannot provide biliary drainage, such as in cases of failed cannulation, duodenal obstruction, or altered anatomy (e.g., after gastric bypass), endoscopic ultrasound-guided biliary drainage (EUS-BD) has been recommended by the American Society for Gastrointestinal Endoscopy as the preferred technique over percutaneous transhepatic biliary drainage for relieving biliary obstruction. Recently, EUS-BD has been explored as the primary technique for relieving biliary obstruction. The proposed benefits include higher technical success, shorter procedural time, a lower risk of pancreatitis, and longer stent patency. However, the results of randomized controlled studies have been conflicting. Hence, the aim of this article is to review the evidence from randomized controlled trials comparing EUS-BD with ERCP as the primary method of biliary drainage for malignant distal biliary obstruction.
  • 1,404 View
  • 97 Download
Close layer
Non-invasive colorectal cancer screening: emerging tools and clinical evidence
Hyoung Il Choi, Jae Myung Cha
Clin Endosc 2026;59(5):732-740.   Published online December 3, 2025
DOI: https://doi.org/10.5946/ce.2025.246
AbstractAbstract PDF
The fecal immunochemical test (FIT) is a widely used non-invasive screening method for colorectal cancer (CRC) in many countries, valued for its simplicity, affordability, and reasonable sensitivity. Typically recommended on an annual or biennial basis, the FIT is effective in reducing CRC incidence and mortality by facilitating early detection. Stool DNA tests, including multitarget DNA tests and DNA methylation assays, demonstrate higher sensitivity than FIT for CRC and advanced adenomas, although they have slightly lower specificity and higher cost. These tests are generally performed at longer intervals, such as every 3 years, and are useful alternatives for individuals who are unwilling or unable to undergo a colonoscopy. Emerging non-invasive CRC screening tools, such as liquid biopsy, microRNA, microbiome tests, and urine-based tests, are being developed to improve patient compliance and test convenience. In particular, liquid biopsy offers a minimally invasive option that may be more acceptable to populations hesitant to undergo stool-based tests. Furthermore, the integration of machine learning with metagenomic sequencing data has shown promise in distinguishing patients with CRC from healthy individuals. As CRC screening evolves, these novel approaches may enable the development of more personalized, accessible, and effective screening strategies, ultimately improving adherence and reducing CRC-related mortality.

Citations

Citations to this article as recorded by  
  • Colorectal cancer screening: Technological innovation from single modality testing to a comprehensive intelligent prevention and control system
    Dan Ren, Man-Li Cui, Ming-Xin Zhang
    World Chinese Journal of Digestology.2026; 34(3): 220.     CrossRef
  • Liquid biopsies in colorectal cancer screening and diagnosis
    Xiao-Zhe Bai, Sa-Chu La Bao, Xu-Qian Zhang, Zhen-Ni Yang
    World Journal of Gastrointestinal Oncology.2026;[Epub]     CrossRef
  • The Role of Computational Models in the Detection of Colorectal Carcinoma and Precancerous Lesions
    Jelena Zivic, Stefan Jakovljevic, Milos Zivic, Andrija Rancic, Dušan Radojevic, Mladen Maksic, Ilija Ilic, Nikola Milutinovic, Nikola Mirkovic, Stevan Eric, Bojan Stojanovic, Radojica Stolic, Giulio Antonelli, Natasa Zdravkovic
    International Journal of Molecular Sciences.2026; 27(17): 7943.     CrossRef
  • 7,849 View
  • 490 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Systematic Review and Meta-analysises
Safety and effectiveness of endoscopic ultrasound-guided coil plus glue vs. direct endoscopic glue injection for the treatment of gastric varices: a systematic review and meta-analysis
Zahid Ijaz Tarar, Mustafa Gandhi, Umer Farooq, Gopala K. Konduri, Ahmad Zain, Zohaib Ahmed, Baltej Singh, Ryan J. Law, Nirav Thosani
Clin Endosc 2026;59(5):741-753.   Published online September 28, 2026
DOI: https://doi.org/10.5946/ce.2025.251
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Although endoscopic glue injection is the conventional first-line treatment for gastric variceal (GV) bleeding, a large body of evidence supports the safety and effectiveness of endoscopic ultrasound (EUS)-guided coil and glue injections. We compared the safety and efficacy of these two modalities.
Methods
A random-effects model was used for the pooled estimates. The outcomes of interest were the odds of technical success, GV obliteration, adverse events, rebleeding, reintervention, and pulmonary embolization (PE).
Results
Eight studies involving 659 patients (EUS-guided coil+glue, n=200; endoscopic glue, n=459) were included in the meta-analysis. The rebleeding (odds ratio [OR], 0.28, 95% confidence interval [CI], 0.16–0.51; I2=0%) and reintervention (OR, 0.28; 95% CI, 0.15–0.52; I2=0%) rates were significantly lower in the EUS-guided coil+glue. EUS-guided coil+glue group had higher rates (OR, 4.56; 95% CI, 2.04 –10.19; I2=30%) of GV obliteration after the first session. No difference in the odds of technical success (OR, 2.03; 95% CI, 0.50–8.22; I2=0%), adverse events (OR, 1.19; 95% CI, 0.44–3.20; I2=45%), abdominal pain (OR, 1.17; 95% CI, 0.36–3.82; I2=44%) fever (OR, 1.09; 95% CI, 0.41–2.92; I2=0%), PE (OR, 0.52; 95% CI, 0.19–1.47; I2=0%) and all-cause mortality (OR, 0.67; 95% CI, 0.32–1.40; I2=0%) was identified.
Conclusions
EUS-guided coil and glue injections are safe and effective for the treatment of gastric varices.
  • 1,221 View
  • 78 Download
Close layer
Hybrid endoscopic submucosal dissection enhances efficiency with comparable curative outcomes: a Bayesian meta-analysis, systematic review, and Monte Carlo simulation of randomized controlled trials
Ashesh Das, Arpitha Sirichandana Baggu, Param Darpan Sheth, Nihal Reddy Bandi, Chandana Priya Digumurthy, Urvashi Bharia, Shah Kavya Hiteshkumar, Krishna Sai Kiran Sakalabaktula, Shankar Biswas, Riyakumari Patel, Meenakshi Reddy Yathindra, Venkata Dileep Kumar Veldi
Clin Endosc 2026;59(5):754-764.   Published online September 22, 2026
DOI: https://doi.org/10.5946/ce.2025.439
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Gastrointestinal (GI) cancers accounted for 3.24 million deaths worldwide in 2022. Endoscopic submucosal dissection (ESD) enables en bloc resection of early neoplasms but is time-intensive and technically challenging. Hybrid ESD (H-ESD), which combines dissection with snare polypectomy, may improve efficiency while maintaining efficacy.This Bayesian meta-analysis of randomized controlled trials (RCTs) compares the safety and efficacy of H-ESD with conventional ESD (C-ESD).
Methods
We searched the PubMed, Embase, Cochrane, Scopus databases for RCTs comparing hybrid and C-ESD for superficial GI neoplasms. Bayesian modeling in Just Another Gibbs Sampler used normal-normal hierarchies for procedure time and logRR for binary outcomes with weakly informative priors. Frequentist analyses were performed using Der-Simonian-Laird τ². Heterogeneity was assessed using I²/τ².
Results
H-ESD showed comparable en bloc (RR, 0.97; 95% [CrI], 0.92–1.03; I²=22.8%) and R0 resection rates (RR, 0.97; 95% CrI, 0.90–1.04; I²=0%). Procedure time decreased significantly with H-ESD (MD, –18.05; 95% CrI, –27.77 to –8.33 minutes; I²=66.5%). Adverse events (RR, 1.08; 95% CrI, 0.44–2.63) and perforations (RR, 1.05; 95% CrI, 0.34–3.19) were similar between the two procedures.
Conclusions
H-ESD matches C-ESD in curative resection while reducing the procedure time, offering a safer and more efficient alternative. Larger RCTs are needed to confirm the long-term benefits.
  • 1,505 View
  • 98 Download
Close layer
Editorials
Anterior or posterior peroral endoscopic myotomy: anatomy may matter more than orientation
Yuna Kim, Young Hoon Youn
Clin Endosc 2026;59(5):765-767.   Published online September 30, 2026
DOI: https://doi.org/10.5946/ce.2026.481
PDF
  • 501 View
  • 32 Download
Close layer
A simple model for a complex procedure: broadening access to endoscopic retrograde cholangiopancreatography simulation
Kyu-Hyun Paik
Clin Endosc 2026;59(5):768-770.   Published online September 30, 2026
DOI: https://doi.org/10.5946/ce.2026.409
PDF
  • 597 View
  • 34 Download
Close layer
More frames or better labels?: training data and computer-aided detection of sessile serrated lesions
Min-Jae Kim
Clin Endosc 2026;59(5):771-773.   Published online September 30, 2026
DOI: https://doi.org/10.5946/ce.2026.439
PDF
  • 547 View
  • 35 Download
Close layer
A double-edged sword in the very elderly: to screen or not to screen with colonoscopy?
Jaeyoung Chun
Clin Endosc 2026;59(5):774-775.   Published online September 30, 2026
DOI: https://doi.org/10.5946/ce.2026.428
PDF
  • 520 View
  • 39 Download
Close layer
Original Articles
Feasibility and diagnostic performance of heparinized wetsuction and single-pass single-needle actuation endoscopic ultrasound-guided tissue acquisition for subepithelial lesions in Japan: a single-center retrospective study
Kotaro Takeshita, Satoshi Asai, Kenji Matsuo, Takumi Sugihara, Kensei Kawasaki, Aoi Koizumi, Sayuri Hashimoto, Kaho Takagi, Yoshihiro Shima, Tomoya Hashimura, Kento Hisamatsu, Yuma Fujita, Yuichiro Hamamoto, Shuta Otachi, Yuki Kano, Eisuke Nakao, Eisuke Akamine, Yoshinobu Hirose
Clin Endosc 2026;59(5):776-786.   Published online August 13, 2026
DOI: https://doi.org/10.5946/ce.2025.354
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Heparinized wet suction (HEP) and the single-pass single-needle actuation method (HEP1p1a) are promising for endoscopic ultrasound-guided tissue acquisition (EUS-TA) because they improve specimen quality. However, its applicability in the biopsy of subepithelial lesions (SELs) remains unexamined. Therefore, this study evaluated the clinical utility of EUS-TA using HEP1p1a in SELs.
Methods
This study analyzed data of patients who underwent EUS-TA using HEP1p1a between January 2019 and May 2025. The primary outcome was pathological differentiation. Furthermore, clinical data of EUS-TA using HEP1p1a were compared with those using HEP and other than 1p1a; subgroup analysis was performed comparing the clinical outcomes between SELs ≥20 and <20 mm.
Results
Thirty-six patients underwent EUS-TA using HEP1p1a (technical success rate: 100%): 24 and 12 patients with lesions ≥20 and <20 mm, respectively. The rates of achieving pathological differentiation, immunohistochemical success, and definitive histologic diagnosis were 94.4%, 89.3%, and 86.1%, respectively; for SELs ≥20 mm, they were 100%, 94.7%, and 95.8%, respectively. Cellularity and maximum length of white sequential specimens were better in patients with lesions ≥20 mm. No adverse events were observed during or after the procedures.
Conclusions
High diagnostic performance and specimen quality were demonstrated with EUS-TA using HEP1p1a for SELs, particularly those >20 mm. To acquire high-quality specimens while minimizing blood contamination, EUS-TA with HEP1pla for SELs might be an effective approach.
  • 1,364 View
  • 163 Download
Close layer
Anterior versus posterior peroral endoscopic myotomy: a prospective randomized controlled trial from a Thai tertiary center
Tharathorn Suwatthanarak, Siwaree Maneesoi, Chatbadin Thongchuam, Thawatchai Akaraviputh, Vitoon Chinswangwatanakul, Somchai Leelakusolvong, Chainarong Phalanusitthepa
Clin Endosc 2026;59(5):787-796.   Published online August 13, 2026
DOI: https://doi.org/10.5946/ce.2025.407
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Background
/Aims: Achalasia is an esophageal motility disorder. Peroral endoscopic myotomy is widely used for all subtypes; however, randomized head-to-head evidence comparing the anterior and posterior approaches remains limited. We compared efficacy, safety, and reflux outcomes.
Methods
We conducted a single-center, single-blind, prospective randomized controlled trial from February 2023 to August 2024. Twenty-eight patients with achalasia types I–III were randomized to anterior or posterior peroral endoscopic myotomy. The primary outcomes were esophageal acid exposure at 3 months (24-hour pH monitoring) and clinical success (Eckardt score ≤3). The secondary outcomes were procedural parameters, complications, timed barium esophagography, manometry, and reflux esophagitis.
Results
Baseline characteristics were comparable between the groups. Procedural metrics and complication rates were similar and mild, with no severe adverse events. At 12 months, both groups showed significant symptom relief, reduced Eckardt scores, and decreased lower esophageal sphincter pressure. Posterior myotomy yielded a higher proportion of abnormal DeMeester scores (57.1% vs. 28.6%, p=0.14), although reflux esophagitis remained mild and comparable between the groups.
Conclusions
Posterior peroral endoscopic myotomy demonstrated comparable efficacy, safety, and reflux outcomes. The anterior approach improved clearance on timed barium esophagography; however, both approaches achieved durable symptom control with acceptable safety profiles, supporting posterior myotomy as a valid alternative.

Citations

Citations to this article as recorded by  
  • Anterior or posterior peroral endoscopic myotomy: anatomy may matter more than orientation
    Yuna Kim, Young Hoon Youn
    Clinical Endoscopy.2026; 59(5): 765.     CrossRef
  • 1,300 View
  • 141 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Real-world management and in-hospital outcomes of foreign body-associated esophageal perforations in the United States: a national retrospective cohort study
Stephanie Rodriguez, Spencer R. Goble, Gaurav Suryawanshi, Khalid Ahmed, Nabeel Azeem
Clin Endosc 2026;59(5):797-805.   Published online September 18, 2026
DOI: https://doi.org/10.5946/ce.2025.411
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Esophageal perforations can be managed conservatively, endoscopically, or surgically. We aimed to characterize the outcomes of these approaches and assess the impact of intervention timing.
Methods
We retrospectively analyzed hospitalizations in the National Inpatient Sample from 2016 to 2022 for foreign body-associated esophageal perforations. Patients were grouped into endoscopic, surgical, or conservative management. Outcomes included mortality, respiratory failure, sepsis, hemorrhage, parenteral nutrition, and gastrostomy.
Results
Among the 2,045 patients, 145 (7.1%) underwent endoscopic management, 190 (9.3%) underwent surgical management, and 1,710 (83.6%) received conservative treatment. Food impaction accounted for 76% of foreign bodies. The mortality rates were 0%, 5.3%, and 2.9%, respectively. Respiratory failure occurred in 17.2% of endoscopically managed patients and 42.1% of surgically managed patients. Surgical cases had higher use of parenteral nutrition (15.8%) and gastrostomy (31.6%), whereas conservative management had the highest hemorrhage rate (18.1%). Intervention timing was not significantly associated with outcomes.
Conclusions
Most foreign body-associated esophageal perforations are managed conservatively. Among patients selected for intervention, endoscopic management was associated with lower rates of mortality, selected complications, and healthcare utilization than surgery. These findings reflect clinical triage pathways and should be interpreted cautiously, given potential selection bias, confounding by indication, and administrative data limitations.
  • 1,009 View
  • 89 Download
Close layer
Development and preliminary evaluation of a novel low-cost endoscopic retrograde cholangiopancreatography simulator with electrocautery training capability: a proof-of-concept study from India
Avinash Tiwari, Duncan Khanikar
Clin Endosc 2026;59(5):806-820.   Published online August 13, 2026
DOI: https://doi.org/10.5946/ce.2025.438
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Endoscopic retrograde cholangiopancreatography (ERCP) requires extensive training, with around 350–400 supervised cases being required for proficiency. Existing simulators face costs, limited availability, and limited realism. Therefore, we developed and preliminarily evaluated a minimal ERCP training model that incorporated electrocautery capabilities.
Methods
A five-phase development process was employed, including needs assessment, iterative prototyping with material optimization, technical performance testing across 50 training sessions, comparative analysis against existing simulators, and preliminary expert evaluation by eight experienced endoscopists (mean ERCP experience: 12.3±4.2 years). The primary outcomes included verification of functional capability, cost analysis, durability assessment, and expert ratings on 5-point Likert scales for realism and educational value.
Results
The simulator successfully achieved biliary cannulation in 48/50 sessions (96.0%), supported needle knife precut training with functional electrocautery, and demonstrated compatibility with C-arm fluoroscopy, providing adequate contrast visualization. The total material cost per unit was 47.32 United States dollars (USD), compared to 180,000–250,000 USD for commercial virtual reality simulators. The model withstood 50 sessions without structural failure (onion bulb replacement was required every 8.2±1.4 precut attempts). Expert ratings indicated high scores for anatomical realism (4.1±0.6), tactile feedback (3.9±0.7), and educational value (4.4±0.5).
Conclusions
This novel, low-cost ERCP simulator demonstrated technical feasibility and face validity. This proof-of-concept requires formal prospective validation studies to establish construct validity, concurrent validity, and educational effectiveness through trainee learning outcomes before conclusions regarding the impact on clinical training can be drawn. The innovation addresses significant accessibility barriers but represents preliminary evidence that requires formal educational validation.

Citations

Citations to this article as recorded by  
  • A simple model for a complex procedure: broadening access to endoscopic retrograde cholangiopancreatography simulation
    Kyu-Hyun Paik
    Clinical Endoscopy.2026; 59(5): 768.     CrossRef
  • 1,913 View
  • 133 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Impact of expert-curated video training data on computer-aided detection of sessile serrated lesions: a retrospective study in Korea
Jaehee Han, Sang-Il Oh, Piljoo Kim, Kyung-Nam Kim
Clin Endosc 2026;59(5):821-832.   Published online August 20, 2026
DOI: https://doi.org/10.5946/ce.2025.471
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Background
/Aims: Computer-aided detection (CADe) improves adenoma detection; however, its performance for sessile serrated lesion (SSL) detection remains inconsistent. We hypothesized that models trained on expert-curated, histopathologically-confirmed datasets would improve SSL detection compared to models trained on public datasets without verified labels.
Methods
Two CADe models with identical Visual Geometry Group 16 architectures were trained using different datasets: Model A on public datasets (~54,000 frames) and model B on a histopathologically-confirmed private dataset (~120,000 frames) derived from examinations performed by endoscopists with adenoma detection rates of >35%. Validation was conducted using 31 independent colonoscopy videos obtained from another endoscopist. Diagnostic performance was evaluated using event- and frame-based analyses.
Results
Model B demonstrated a significantly higher event-based sensitivity than model A (99.7% vs. 39.9%, p<0.001). The detection of SSLs was markedly improved with model B. Frame-based sensitivity and F1-score were also higher for model B. Although model B generated more false positives per video (2.55 vs. 0.16, p<0.001), these alerts were brief and unlikely to meaningfully interfere with the endoscopic workflow.
Conclusions
CADe models trained on expert-curated, histopathologically-confirmed datasets showed improved detection of neoplastic colorectal lesions, including SSLs, compared to models trained on public datasets. These findings highlight the importance of clinically curated datasets for optimizing the CADe performance for subtle colorectal lesions.

Citations

Citations to this article as recorded by  
  • More frames or better labels?: training data and computer-aided detection of sessile serrated lesions
    Min-Jae Kim
    Clinical Endoscopy.2026; 59(5): 771.     CrossRef
  • 1,369 View
  • 137 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Predicting retention and rethinking removal of pancreatic duct stents with a standardized protocol: a United Statesbased retrospective study
Divyanshoo R. Kohli, Xiang Yu Gao, Wichit Srikureja, Jack Brandabur, Shih-Ting Chiu, Nishant Puri
Clin Endosc 2026;59(5):833-842.   Published online August 13, 2026
DOI: https://doi.org/10.5946/ce.2025.327
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Background
/Aims: Pancreatic duct (PD) stent selection impacts migration and retention. We evaluated risk factors for migration versus inappropriate retention of PD stents at a high volume center using a standardized stent management protocol.
Methods
Patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) with PD stenting were retrospectively categorized by stent status at 2 weeks post-ERCP. Spontaneous migration was defined as absence of a PD stent on follow-up imaging, while inappropriate retention was defined as persistence of a non-flanged PD stent within the duct. The primary endpoint was PD stent retention at 2 weeks. Secondary endpoints included predictors of inappropriate retention and the need for endoscopic stent removal.
Results
A total of 482 patients underwent ERCP for biliary (n=289), pancreatic (n=181), or dual (n=12) indications. Non-flanged PD stents for biliary vs. pancreatic indications were 74.4% vs. 31.5% (p<0.001). Among 425 patients with follow-up imaging, predictors of PD stent retention included internal flanges (odds ratio [OR], 6.39; 95% confidence interval [CI], 3.29–12.67), pancreatic indication (OR, 2.23; 95%CI, 1.22–4.07), and stent length >3cm (OR, 2.5; 95% CI, 1.23–5.07). Inappropriate retention of non-flanged stents occurred in 29 patients (12.5%), with only 5 (2.2%) requiring endoscopic removal due to mechanical obstruction.
Conclusions
Inappropriate retention of short, narrow caliber, non flanged PD stents is infrequent and rarely requires endoscopic removal.
  • 1,664 View
  • 137 Download
Close layer
Effectiveness and safety of screening colonoscopy in adults aged 75 years and older: a retrospective cohort study from Korea
Juyoung Lee, Mina Kim, Gwang Hyo Yim, Hyeong Ho Jo, Joong Goo Kwon, Eun Young Kim, June Hwa Bae
Clin Endosc 2026;59(5):843-850.   Published online September 18, 2026
DOI: https://doi.org/10.5946/ce.2026.020
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
ackground/Aims: The role of screening colonoscopy in older adults remains controversial because of procedural risks and limited life expectancy. We evaluated the diagnostic yield, procedural success, and safety of screening colonoscopy in patients aged ≥75 years.
Methods
We retrospectively reviewed 602 patients aged ≥75 years who underwent screening colonoscopy between January 2013 and December 2024. Patients were stratified into two age groups: 75–79 years (n=486) and ≥80 years (n=116). Baseline characteristics, procedural outcomes, and safety were compared.
Results
Baseline characteristics were comparable between groups. The detection rates were 10.5%, 6.8%, and 0.9% for non-advanced adenoma, advanced adenoma, and colorectal cancer, respectively. Cecal intubation success was high in both groups (98.1% vs. 99.1%, p=0.454), and adequate bowel preparation rates were similar (71.2% vs. 72.4%, p=0.880). Sedation was used less frequently in patients aged ≥80 years (65.5% vs. 76.7%, p=0.013). Complications were rare (1.5%) and comparable between groups, with only mild events.
Conclusions
Screening colonoscopy in adults aged ≥75 years demonstrated high procedural success, substantial neoplasia detection rates, and low adverse event rates, with comparable outcomes in patients aged ≥80 years. However, overall clinical benefit should be interpreted cautiously, particularly in those aged ≥80 years, supporting an individualized approach.

Citations

Citations to this article as recorded by  
  • A double-edged sword in the very elderly: to screen or not to screen with colonoscopy?
    Jaeyoung Chun
    Clinical Endoscopy.2026; 59(5): 774.     CrossRef
  • 994 View
  • 115 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Images of Issue
Obstructive jaundice caused by a giant common hepatic artery aneurysm
Akinobu Koiwai, Morihisa Hirota, Yuki Miyashita, Nana Inomata, Kennichi Satoh
Clin Endosc 2026;59(5):851-852.   Published online March 30, 2026
DOI: https://doi.org/10.5946/ce.2025.306
PDF
  • 1,400 View
  • 202 Download
Close layer
Rare complication of plastic endoscopic retrograde biliary drainage stent placement: bile duct perforation
Akinobu Koiwai, Morihisa Hirota, Yuki Miyashita, Nana Inomata, Kennichi Satoh
Clin Endosc 2026;59(5):853-854.   Published online February 2, 2026
DOI: https://doi.org/10.5946/ce.2025.400
PDF
  • 1,616 View
  • 252 Download
Close layer
Videos of Issue
Successful gastric endoscopic submucosal dissection using an external second bending device
Daisuke Minezaki, Koshiro Tsutsumi, Ryo Ogawa, Kazuhiro Mizukami
Clin Endosc 2026;59(5):855-856.   Published online December 24, 2025
DOI: https://doi.org/10.5946/ce.2025.262
PDFSupplementary Material
  • 2,335 View
  • 209 Download
Close layer
Endoscopic ultrasound-guided cyanoacrylate injection for jejunal varices at the hepaticojejunostomy site using a forward-viewing echoendoscope
Kosuke Okuwaki, Masafumi Watanabe, Shuichiro Iwasaki, Nobuyuki Nishizawa, Akihiro Tamaki, Chika Kusano
Clin Endosc 2026;59(5):857-858.   Published online September 4, 2026
DOI: https://doi.org/10.5946/ce.2025.333
PDFSupplementary Material
  • 1,116 View
  • 38 Download
Close layer
Brief Report
Single-session dual peroral endoscopic myotomy: near-complete esophageal myotomy for combined Zenker’s diverticulum and Jackhammer esophagus in a patient with longstanding dysphagia
Biswa Ranjan Patra, Nagesh Kamat, Sanil Parekh, Sharan Malipatil, Onkar Pensalwar, Shivdas Medabalmewar, Sehajad Vora, Amit Maydeo
Clin Endosc 2026;59(5):859-863.   Published online June 24, 2026
DOI: https://doi.org/10.5946/ce.2025.456
PDF

Citations

Citations to this article as recorded by  
  • Third space endoscopy in 2026 and beyond
    Amit Maydeo, Bu’Hussain Hayee, Biswa Ranjan Patra, Nagesh Kamat, Amanda Lim, Rubin George
    Frontline Gastroenterology.2026; 17(e1): e84.     CrossRef
  • 1,548 View
  • 120 Download
  • 1 Web of Science
  • 1 Crossref
Close layer
Boost Your Learning with Quiz
A duodenal mass with biliary obstruction in a 60-year-old man
Jun Heo, Min Kyu Jung, Yoo Na Kang
Clin Endosc 2026;59(5):864-867.   Published online September 30, 2026
DOI: https://doi.org/10.5946/ce.2026.315
PDF
  • 1,022 View
  • 37 Download
Close layer
Letters to the Editor
Feasibility of ex vivo single-operator cholangioscopy in liver grafts
Jimin Han
Clin Endosc 2026;59(5):868-869.   Published online August 11, 2026
DOI: https://doi.org/10.5946/ce.2026.205
PDF
  • 631 View
  • 46 Download
Close layer
Real-world computer-aided detection for adenoma detection: promising but context-dependent
Yunho Jung
Clin Endosc 2026;59(5):870-871.   Published online September 15, 2026
DOI: https://doi.org/10.5946/ce.2026.330
PDF
  • 542 View
  • 28 Download
Close layer
Artificial intelligence in upper gastrointestinal endoscopy: what detection rates cannot tell us
Joon Sung Kim
Clin Endosc 2026;59(5):872-873.   Published online September 14, 2026
DOI: https://doi.org/10.5946/ce.2026.328
PDF
  • 606 View
  • 32 Download
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP